LRRK2 and Parkinson disease: Finally, another study using fibroblasts from G2019S LRRK2 PD patients and non-manifesting carriers showed that the cells from PD patients had compromised bioenergetic function and an inefficient response to bioenergetic challenge, leading to dysfunctional mitochondrial dynamics (Juarez-Flores et al., 2018).